Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1 1

Status

Completed 2

Sponsor Class

INDUSTRY 2

Study Type

Interventional 2

Sponsor

Cancer Type

Other solid neoplasm 2

Conditions

Stomach Neoplasms 8Adenocarcinoma 7Neoplasms 6Solid Tumors 2Pancreatic Neoplasms 1Metastatic Pancreatic Adenocarcinoma 1Gastric Cancer Adenocarcinoma Metastatic 1Esophageal Neoplasms 1CLDN18.2-positive Gastric Adenocarcinoma 1CLDN18.2-positive Adenocarcinoma of the Gastroesophageal Junction 1Adenocarcinoma Of Esophagus 1

Interventions

Paclitaxel 15atezolizumab 11Gemcitabine 11Carboplatin 9pembrolizumab 8Docetaxel 8Bevacizumab 8Irinotecan 7Injections 6Cetuximab 6Capecitabine 6Sunitinib 5Leucovorin 5Fluorouracil 5Cyclophosphamide 5tocilizumab 4pazopanib 4olaparib 4navitoclax 4liposomal doxorubicin 4Topotecan 4Oxaliplatin 4Nivolumab 4Erlotinib Hydrochloride 4temsirolimus 3spartalizumab 3lenvatinib 3fludarabine 3cobimetinib 3Cisplatin 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Solid Tumors × zolbetuximab × Clear all
NCT01197885 2025-06-13

Efficacy and Safety Study of Multiple Doses of IMAB362 in Patients With Advanced Gastroesophageal Cancer

Astellas Pharma Inc

Phase 2 Completed
54 enrolled
Other solid neoplasm

Solid Tumors

NCT00909025 2024-11-21

Safety and Tolerability Study of Claudiximab in Patients With Advanced Gastroesophageal Cancer

Astellas Pharma Inc

Phase 1 Completed
15 enrolled
Other solid neoplasm

Solid Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡